Achieving Sustained Treatment Response: The Need for Immunotherapy in Chronic HBV

Time: 1:30 pm
day: Day Two

Details:

• Evaluating the role of T-cells in clearing virus infections, including HBV epitope targets for CD4+ and CD8+ T cells

• Understanding the analogy between HPV and HBV chronic infections with attention to the special role of the liver

• Reviewing the synthetic Long Peptide vaccine technology in HBV

• Exploring the relationship between immune response and clinical response

Speakers: